Finland· FI-REL-REL57132
Voxzogo
A vosoritide product containing vosoritide, registered in Finland by Biomarin International Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Vosoritide is registered in 10 of 19 countries.
Countries holding a registration under ATC M05BX07 (vosoritide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Vosoritide · ATC M05BX07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Vosoritide
- Manufacturer
- Biomarin International Limited
- Country
- Finland (FI)
- ATC code
- M05BX07
- ATC class
- Vosoritide
- Defined daily dose
- 0.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vosoritide in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsVoxzogo 0,4 mg, poeder en oplosmiddel voor oplossing voor injectieBioMarin International Limited
- SwitzerlandVoxzogo 0.4 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungDRAC AG
- CzechiaVOXZOGOBioMarin International Limited, Dublin
- SpainVOXZOGO 0,4 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBiomarin International Limited
- FranceVOXZOGO 0,4 mg, poudre et solvant pour solution injectableBIOMARIN INTERNATIONAL LIMITED (IRLANDE)
- IrelandVoxzogo 0.4 mg powder and solvent for solution for injectionBiomarin International Limited
- IcelandVoxzogoBioMarin International Limited
- Japanボソリチド（遺伝子組換え）ＢｉｏＭａｒｉｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｊａｐａｎ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Voxzogo
- Liechtenstein · Voxzogo
- Norway · Voxzogo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c2b33be-4248-4c60-91fd-134792efe3e7 GET /v1/drugs/9c2b33be-4248-4c60-91fd-134792efe3e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": "Ihon alle",
"ddd_unit": null,
"strength": "0.4 mg",
"atc_label": "vosoritidi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/21/1577/001",
"fimea_rel_id": "REL57132",
"authorised_at": "2021-08-26"
}See everything about vosoritide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.